ALKION is a startup based in France, most recent round Series A.
Based in France, ALKION is a startup founded in 2016. Its most recent tracked round is Series A.
Alkion BioInnovations develops plant tissue propagation and bioengineering technologies to produce high-value ingredients such as active pharmaceutical ingredients (APIs), complex extracts, and recombinant proteins from plant biomass. Their patented bioproduction platform uses a carbon-neutral approach to address global vaccine access and the demand for therapeutic cannabinoids and sweet proteins.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.